Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1997-11-13
pubmed:abstractText
It has been reported previously that immunization with recombinant protein containing the two epidermal growth factor (EGF)-like modules from merozoite surface protein 1 (MSP-1) of Plasmodium yoelii (strain YM) protects mice against a lethal blood-stage challenge with the same parasite strain. Since MSP-1 is expressed in both liver- and blood-stage schizonts and on the surface of merozoites, we evaluated the effectiveness of immunization with recombinant proteins containing either the individual or the two combined EGF-like modules in producing a protective response against a sporozoite challenge. The recombinant protein expressing the combined EGF-like modules of the YM strain protected mice against a homologous sporozoite challenge, and sterile protection, as defined by the absence of detectable blood-stage parasites, was observed in the majority of the mice. In contrast, mice immunized with recombinant P. yoelii YM MSP-1 were not protected against a heterologous challenge with sporozoites from strain 265 BY of P. yoelii. The lack of protection may be explained by differences identified in the amino acid sequences of MSP-1 for the two strains. A recombinant protein containing the two EGF-like modules of MSP-1 from P. yoelii 265 BY was produced and used to immunize mice. These mice were protected against a homologous challenge with sporozoites of P. yoelii 265 BY. The results suggest that a recombinant MSP-1 has potential as a vaccine against malaria, but its efficacy may be limited by sequence polymorphism and selection of variants.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-1381314, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-15275468, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-15463703, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-1620166, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-1624802, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-1625908, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-1775158, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-1878339, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-1980910, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-1991487, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-2052407, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-2201546, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-2258697, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-2358778, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-2447163, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-2467942, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-2469336, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-2477452, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-2509909, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-2797063, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-2871847, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-3085218, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-3275737, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-3308506, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-4948418, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-6725950, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-6752328, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-7501423, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-7516416, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-7602100, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-7628566, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-7718511, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-8015856, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-8104409, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-8363656, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-8458376, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-8515786, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-8577318, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-8617331, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-8627050, http://linkedlifedata.com/resource/pubmed/commentcorrection/9353014-8751907
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0019-9567
pubmed:author
pubmed:issnType
Print
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4419-23
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.
pubmed:affiliation
U313 INSERM, CHU Pitié-Salpêtrière, Paris, France. renia@icgm.cochin.inserm.fr
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't